United States · Funded startup

Who invested in Modernizing Medicine

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Valuation: $500M, Oct 2024

Funding summaryUpdated 26 Oct 2026

$231Mraised across 1 round since 2017, from 1 source

Latest round
Round, $231MMay 2017
Investors
1
See who backed them

The rounds

  1. May 2017
    Round$231M

    Reported by FinSMEsSEC filing: $206M sold, first sale May 2017

Founders and team

From the SEC filings it signed: 5 on the team.

  • Daniel CaneExecutive Officer, Directori
  • Joseph HarpazExecutive Officeri
  • Mark FleisherExecutive Officeri
  • Michael SherlingExecutive Officer, Directori
  • Michelle ScheerExecutive Officeri

On the board, as filediAmr KronfolAndrew ParkBarry MosheimGary SteeleGina LoftenJean BuaPhillip Pead

Everyone who backed them

Warburg PincusPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Modernizing Medicine

Who invested in Modernizing Medicine?

Modernizing Medicine's investors include Warburg Pincus.

How much has Modernizing Medicine raised?

Modernizing Medicine has raised $231M across 1 round since 2017.

When did Modernizing Medicine last raise?

Modernizing Medicine's most recent round was an Undisclosed round of $231M in May 2017.

What was Modernizing Medicine's biggest round?

Its most recent round, $231M in May 2017, is also its largest on record.

Who backed Modernizing Medicine first?

Modernizing Medicine's first round on record, in May 2017, was backed by Warburg Pincus.

What stage is Modernizing Medicine at?

Modernizing Medicine's latest named round is an Undisclosed round, in May 2017.

Where is Modernizing Medicine based?

Modernizing Medicine is based in the United States.

Companies like Modernizing Medicine

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.